Michael Chi Sells 13,750 Shares of Hims & Hers Health (NYSE:HIMS) Stock

Hims & Hers Health, Inc. (NYSE:HIMS) COO Michael Chi sold 13,750 shares of the business’s stock in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $36.71, for a total value of $504,762.50. Following the completion of the sale, the chief operating officer directly owned 305,161 shares of the company’s stock, valued at approximately $11,202,460.31. The trade was a 4.31% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Michael Chi also recently made the following trade(s):

• On Friday, October 10th, Michael Chi sold 900 shares of Hims & Hers Health stock. The shares were sold at an average price of $58.25, for a total transaction of $52,425.00.
• On Wednesday, September 24th, Michael Chi sold 2,100 shares of Hims & Hers Health stock. The shares were sold at an average price of $56.52, for a total transaction of $118,692.00.

Hims & Hers Health Stock Down 0.7%

HIMS stock traded down $0.23 during trading hours on Thursday, hitting $34.74. The company’s stock had a trading volume of 11,410,870 shares, compared to its average volume of 30,867,883. The stock has a 50 day moving average price of $42.69 and a two-hundred day moving average price of $48.78. Hims & Hers Health, Inc. has a 12 month low of $23.97 and a 12 month high of $72.98. The company has a market capitalization of $7.91 billion, a PE ratio of 64.33, a price-to-earnings-growth ratio of 7.29 and a beta of 2.41. The company has a quick ratio of 1.64, a current ratio of 1.88 and a debt-to-equity ratio of 1.67.

Hims & Hers Health (NYSE:HIMS) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.03). The business had revenue of $598.98 million during the quarter, compared to analyst estimates of $578.99 million. Hims & Hers Health had a net margin of 6.05% and a return on equity of 24.67%. The firm’s revenue for the quarter was up 49.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.32 EPS. On average, equities research analysts expect that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current year.

Hims & Hers Health announced that its Board of Directors has authorized a share repurchase program on Monday, November 17th that authorizes the company to repurchase $250.00 million in shares. This repurchase authorization authorizes the company to buy up to 3% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.

Institutional Investors Weigh In On Hims & Hers Health

Several hedge funds have recently made changes to their positions in the stock. VIRGINIA RETIREMENT SYSTEMS ET Al raised its holdings in Hims & Hers Health by 0.8% in the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 25,600 shares of the company’s stock valued at $1,452,000 after acquiring an additional 200 shares in the last quarter. Smartleaf Asset Management LLC increased its position in shares of Hims & Hers Health by 15.7% during the first quarter. Smartleaf Asset Management LLC now owns 1,672 shares of the company’s stock valued at $49,000 after purchasing an additional 227 shares during the period. GAMMA Investing LLC increased its position in shares of Hims & Hers Health by 6.1% during the third quarter. GAMMA Investing LLC now owns 4,098 shares of the company’s stock valued at $232,000 after purchasing an additional 236 shares during the period. Concurrent Investment Advisors LLC raised its stake in shares of Hims & Hers Health by 1.8% in the third quarter. Concurrent Investment Advisors LLC now owns 13,984 shares of the company’s stock valued at $793,000 after purchasing an additional 252 shares in the last quarter. Finally, Bessemer Group Inc. lifted its position in Hims & Hers Health by 105.8% in the second quarter. Bessemer Group Inc. now owns 607 shares of the company’s stock worth $30,000 after purchasing an additional 312 shares during the period. Institutional investors own 63.52% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on HIMS shares. KeyCorp initiated coverage on Hims & Hers Health in a research note on Tuesday, October 21st. They set a “sector weight” rating for the company. Leerink Partnrs upgraded Hims & Hers Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, December 4th. BTIG Research reiterated a “buy” rating and set a $85.00 price target on shares of Hims & Hers Health in a report on Tuesday, November 4th. Weiss Ratings reissued a “hold (c)” rating on shares of Hims & Hers Health in a research report on Monday. Finally, Wall Street Zen downgraded shares of Hims & Hers Health from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $45.50.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.